178 related articles for article (PubMed ID: 35885589)
1. The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics.
Huang HC; Shiu BH; Su SC; Huang CC; Ting WC; Chang LC; Yang SF; Chou YE
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885589
[TBL] [Abstract][Full Text] [Related]
2. Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Ng SC; Wang PH; Lee YC; Lee CY; Yang SF; Shen HP; Hsiao YH
Int J Med Sci; 2019; 16(6):774-782. PubMed ID: 31337950
[TBL] [Abstract][Full Text] [Related]
3. Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Li CC; Hsieh MJ; Wang SS; Hung SC; Lin CY; Kuo CW; Yang SF; Chou YE
Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940762
[TBL] [Abstract][Full Text] [Related]
4. Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Wang B; Hsu CJ; Lee HL; Chou CH; Su CM; Yang SF; Tang CH
Int J Med Sci; 2018; 15(6):653-658. PubMed ID: 29725257
[TBL] [Abstract][Full Text] [Related]
5. Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.
Hsieh CY; Chou YE; Lin CY; Wang SS; Chien MH; Tang CH; Lin JC; Wen YC; Yang SF
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33228130
[TBL] [Abstract][Full Text] [Related]
6. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
7. The Association of
Chen GL; Wang SC; Huang WC; Chang WS; Tsai CW; Li HT; Shen TC; Hsia TC; Bau DT
Anticancer Res; 2019 Oct; 39(10):5375-5380. PubMed ID: 31570432
[TBL] [Abstract][Full Text] [Related]
8. Impact of Matrix Metalloproteinase-8 Genotypes on Colorectal Cancer Risk in Taiwan.
Deng Y; Ke TW; Wang YC; Chin YT; Yueh TC; Hung YC; Mong MC; Yang YC; Chang WS; Shen TC; Bau DT; Tsai CW
Anticancer Res; 2023 Sep; 43(9):3979-3985. PubMed ID: 37648297
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
[TBL] [Abstract][Full Text] [Related]
10. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-2 (-1306 c>t) promoter polymorphism and risk of colorectal cancer in the Saudi population.
Saeed HM; Alanazi MS; Parine NR; Shaik J; Semlali A; Alharbi O; Azzam N; Aljebreen A; Almadi M; Shalaby MA
Asian Pac J Cancer Prev; 2013; 14(10):6025-30. PubMed ID: 24289619
[TBL] [Abstract][Full Text] [Related]
13. Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.
Wu MH; Tzeng HE; Wu CN; Yueh TC; Peng YC; Tsai CH; Wang YC; Ke TW; Pei JS; Chang WS; Tsai CW; Bau DT
Anticancer Res; 2019 Dec; 39(12):6523-6529. PubMed ID: 31810917
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-8 rs11225395 polymorphism correlates with colorectal cancer risk and survival in a Chinese Han population: a case-control study.
Tai J; Sun D; Wang X; Kang Z
Aging (Albany NY); 2020 Oct; 12(19):19618-19627. PubMed ID: 33052136
[TBL] [Abstract][Full Text] [Related]
15. Study on the Relationship between MMP-2, MMP-9 Gene Polymorphisms, and the Risk of Colorectal Cancer.
Peng S; Chen M; Wang C; Liu C; Luo K; Yang L
Evid Based Complement Alternat Med; 2022; 2022():7357160. PubMed ID: 36204131
[TBL] [Abstract][Full Text] [Related]
16. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.
Hettiaratchi A; Hawkins NJ; McKenzie G; Ward RL; Hunt JE; Wakefield D; Di Girolamo N
Br J Cancer; 2007 Mar; 96(5):783-92. PubMed ID: 17311017
[TBL] [Abstract][Full Text] [Related]
17. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Tang Y; Zhu J; Chen L; Chen L; Zhang S; Lin J
Clin Cancer Res; 2008 May; 14(9):2870-7. PubMed ID: 18451255
[TBL] [Abstract][Full Text] [Related]
18. The Contribution of
Yueh TC; Wu CN; Hung YW; Chang WS; Fu CK; Pei JS; Wu MH; Lai YL; Lee YM; Yen ST; Li HT; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2018; 15(3):207-212. PubMed ID: 29695403
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
